Except for historical information contained herein, the information in this site contains forward-looking statements that are subject to risks and uncertainties that may cause actual results to differ materially from the results discussed in the forward-looking statements, particularly those risks and uncertainties inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics. Factors that may cause such a difference include risks related to Dendreon’s limited operating history, risks associated with completing Dendreon’s clinical trials, the risk that the results obtained in one clinical trial will not be obtained in a subsequent clinical trial, the risk that the safety or efficacy results of a clinical trial will not support an application for a biologics license, the risk that the FDA will not approve a product for which a biologics license has been applied, the risks that preclinical development efforts will not generate results that warrant further development of a product candidate, the uncertainty of Dendreon’s future access to capital, the failure by Dendreon to secure and maintain relationships with collaborators, and Dendreon’s dependence on the efforts of third parties, dependence on management, and dependence on intellectual property. Further information on the factors and risks that could affect Dendreon’s business, financial condition, and results of operations are contained in Dendreon’s public disclosure filings with the U.S. Securities and Exchange Commission, which are available at www.sec.gov.
Print page
Email page